MISSISSAUGA, ONTARIO, CANADA --Aug 10, 2007 -- Highlights
- Second quarter revenues up 76% year over year and 38% from the first quarter
- Orders received up 43% to $11.9 million year over year/$33.2 million order backlog
- Cash operating costs down 33% or $3.1 million from the first quarter
- Quarterly net loss down 61% or $5.8 million year over year
Hydrogenics Corporation (Toronto:HYG.TO - News)(NasdaqGM:HYGS - News), a leading developer and manufacturer of hydrogen and fuel cell products, is reporting second quarter and six-month unaudited results. Results are reported in U.S. dollars and are prepared in accordance with Canadian generally accepted accounting principles ("GAAP").
"Last quarter we reported on a restructuring and streamlining of our operations to significantly reduce our annual cash consumption," said Daryl Wilson, President and Chief Executive Officer. "The success of this initiative depended, in part, on achieving an improved order book and deliveries in our OnSite Generation business unit. In the second quarter, we achieved significant increases in both our order book and revenues, giving us confidence that we are on track to deliver meaningfully improved financial performance. At the same time, our sales funnel continues to be strong, bolstering our confidence and positive outlook."
"Our Power Systems business unit continues to achieve positive gross margins by seeding pre-commercial markets with sales of our standard power module products as we gain traction in commercial sales to core backup power and materials handling markets," Wilson added.
Results for the second quarter of 2007 compared to the second quarter of 2006
Revenues were $9.5 million, a 76% increase from the second quarter of 2006 and reflect $3.7 million of incremental OnSite Generation revenues and $0.7 million of increased Power Systems revenues, partially offset by $0.4 million of decreased Test Systems revenues.
Gross profit, expressed as a percentage of revenues, was 10% (negative 15% in 2006) and reflects the absence of $1.8 million of special warranty reserves taken in the second quarter of 2006 as a result of supplier component and other production quality issues as well as higher overhead absorption.
Cash operating costs, a non-GAAP measure, defined as selling, general and administrative expenses, and research and product development expenses less stock-based compensation expenses, were $6.2 million, a 23% decrease from $8.1 million in 2006 and are attributed to the streamlining and cost reduction initiative undertaken during the first quarter of 2007 and the absence of $0.7 million of one-time consulting charges related to Sarbanes-Oxley Act implementation and other business strategy matters.
Net loss was $3.8 million for the second quarter of 2007, a decrease of 61% from $9.6 million in 2006.
Results for the second quarter of 2007 compared to the first quarter of 2007
Revenues were $9.5 million, a 38% increase from the first quarter of 2007 and reflect $3.5 million of incremental OnSite Generation revenues and $0.2 million of increased Power Systems revenues, partially offset by a decrease of $1.1 million of Test Systems revenues.
Gross profit, expressed as a percentage of revenues, was 10% (13% in the first quarter) and reflects a larger proportion of revenues from our OnSite Generation business unit, which has historically generated lower gross profit than other business units and has not yet reflected the full benefits of all corrective measures implemented in recent months.
Cash operating costs were $6.2 million, a decrease of 33% from $9.3 million in the first quarter of 2007 and are attributed to a $2.1 million charge taken in the first quarter of 2007 to streamline our operations and a $1.2 million reduction in research and product development expenditures, offset by $0.2 million of other items.
Net loss was $3.8 million for the second quarter of 2007, a decrease of 54% from $8.3 million in the first quarter of 2007.
Results for the six months ended June 30, 2007 compared to the six months ended June 30, 2006
Revenues were $16.3 million, a $4.8 million or 42% increase from 2006 and reflect increased revenues in each of our business units including OnSite Generation ($3.2 million or 79%), Power Systems ($1.1 million or 55%) and Test Systems ($0.5 million or 9%).
Gross profit, expressed as a percentage of revenues, was 12%, an increase of 10% due to the absence of $1.8 million in special warranty reserves taken in the second quarter of 2006, combined with increased overhead absorption as a result of the resumption of deliveries of our OnSite Generation products.
Cash operating costs were $15.6 million, an increase of 1% from $15.4 million in 2006.
Net loss was $12.1 million, a decrease of 33% from $18.0 million in 2006.
Liquidity
Cash and cash equivalents and short-term investments were $43.9 million as at June 30, 2007. The $7.1 million sequential quarterly decrease in cash and cash equivalents and short-term investments is attributable to: (i) $6.3 million of net cash outflows from operations; (ii) $0.3 million of capital expenditures; and (iii) $0.5 million of net cash outflows from financing activities.
Order backlog
Order backlog as at June 30, 2007 was $33.2 million, as follows (in $ millions):
Q1/07 Orders Orders Q2/07
Backlog Received Delivered Backlog
---------------------------------------------------------------------------
---------------------------------------------------------------------------
OnSite Generation $ 17.8 $ 7.1 $ 5.4 $ 19.5
Power Systems 8.1 1.2 1.7 7.6
Test Systems 4.9 3.6 2.4 6.1
---------------------------------------------------------------------------
Total $ 30.8 $ 11.9 $ 9.5 $ 33.2
---------------------------------------------------------------------------
---------------------------------------------------------------------------
In addition to revenue recognized in the six months ended June 30, 2007, we currently expect to deliver and recognize as revenue, a minimum of two thirds of our total backlog in the remainder of 2007.
Second Quarter Highlights
OnSite Generation
- Booked $7.1 million of new orders and exited the quarter with a $19.5
million order backlog
- Orders received are primarily for industrial applications for glass
manufacturing, metallurgy and generator cooling
- Delivered nine electrolyzers including two for hydrogen refueling
applications
- Significant sequential improvement in quarterly gross margin
Power Systems
- Booked $1.2 million of new orders and exited the quarter with a $7.6
million order backlog
- Within the Backup Power market we:
- pursued additional OEM opportunities in backup power markets
- delivered a DC power field trial unit to a leading telecom carrier
in Europe
- Within the Materials Handling market we:
- have now sold HyPX Power Packs to four of the five top material
handling OEMs
- advanced discussions with end-users for multiple multi-year forklift
deployments
- received our first order for Class 2 forklift trucks
- Within our pre-commercial markets we received our third midibus order for
deployment in Europe
Test Systems
- Booked $3.6 million of new orders and exited the quarter with a $6.1
million order backlog
- The majority of orders awarded in the quarter were for first-time
customers
Conference Call Details
Hydrogenics will hold a conference call to review results on August 10, 2007 at 10:30 a.m. (EDT). To participate in this conference call, please dial 416-641-6111 approximately ten minutes before the call. Alternatively, a live webcast of the conference call will be available on the company website at www.hydrogenics.com. Please visit the website at least ten minutes early to register and download any necessary software. Should you be unable to participate, a replay will be available on our website for two weeks.
About Hydrogenics
Hydrogenics Corporation (www.hydrogenics.com) is a globally recognized developer and provider of hydrogen generation and fuel cell products and services, serving the growing industrial and clean energy markets of today and tomorrow. Based in Mississauga, Ontario, Canada, Hydrogenics has operations in North America, Europe and Asia.
Hydrogenics Corporation
Interim Consolidated Balance Sheets
(in thousands of U.S. dollars)
(unaudited)
---------------------------------------------------------------------------
---------------------------------------------------------------------------
June 30 December 31
2007 2006
---------------------------
Assets
Current assets
Cash and cash equivalents $ 43,857 $ 5,937
Short-term investments - 54,350
Accounts receivable 8,522 9,740
Grants receivable 1,115 1,901
Inventories 16,428 12,718
Prepaid expenses 1,437 1,539
-------------------------
71,359 86,185
Property, plant and equipment 5,141 5,435
Intangible assets 375 500
Goodwill 5,025 5,025
Other non-current assets 28 28
---------------------------
$ 81,928 $ 97,173
---------------------------
---------------------------
Liabilities
Current liabilities
Accounts payable and accrued liabilities $ 19,056 $ 21,380
Unearned revenue 7,359 8,809
---------------------------
26,415 30,189
Long-term debt 5 94
Deferred research and development grants 203 133
---------------------------
26,623 30,416
---------------------------
Shareholders' Equity
Share capital and other equity 321,821 321,094
Deficit (261,126) (249,033)
Accumulated other comprehensive loss (5,390) (5,304)
---------------------------
55,305 66,757
---------------------------
$ 81,928 $ 97,173
---------------------------
---------------------------
Hydrogenics Corporation
Interim Consolidated Statements of Operations
(in thousands of U.S. dollars, except for share and per share amounts)
(unaudited)
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Three months Six months
ended June 30 ended June 30
2007 2006 2007 2006
-----------------------------------------------
Revenues $ 9,465 $ 5,376 $ 16,315 $ 11,512
Cost of revenues 8,500 6,170 14,436 11,253
-----------------------------------------------
965 (794) 1,879 259
-----------------------------------------------
Operating expenses
Selling, general and
administrative 4,947 6,586 11,894 13,224
Research and product
development 1,690 1,967 4,552 3,182
Amortization of property,
plant and equipment 223 266 447 530
Amortization of intangible
assets 62 2,118 125 4,236
-----------------------------------------------
6,922 10,937 17,018 21,172
-----------------------------------------------
Loss from operations (5,957) (11,731) (15,139) (20,913)
-----------------------------------------------
Other income (expenses)
Provincial capital tax (56) (60) (74) (86)
Interest 591 1,060 1,458 2,006
Foreign currency gains
(losses) 1,639 1,118 1,669 1,053
-----------------------------------------------
2,174 2,118 3,053 2,973
-----------------------------------------------
Loss before income taxes (3,783) (9,613) (12,086) (17,940)
Current income tax expense 4 13 7 18
-----------------------------------------------
Net loss for the period $ (3,787) $ (9,626) $ (12,093) $ (17,958)
-----------------------------------------------
-----------------------------------------------
Net loss per share
Basic and diluted $ (0.04) $ (0.11) $ (0.13) $ (0.20)
Weighted average number of
common shares outstanding 91,765,691 91,781,393 91,830,666 91,743,525
Hydrogenics Corporation
Interim Consolidated Statements of Cash Flows
(in thousands of U.S. dollars)
(unaudited)
---------------------------------------------------------------------------
---------------------------------------------------------------------------
Three months Six months
ended June 30 ended June 30
2007 2006 2007 2006
----------------------------------------------
Cash and cash equivalents
provided by (used in)
Operating activities
Net loss for the period $ (3,787) $ (9,626) $ (12,093) $ (17,958)
Items not affecting cash
Amortization of property,
plant and equipment 375 447 801 893
Amortization of intangible
assets 62 2,118 125 4,236
Unrealized foreign exchange
(gains) losses 189 15 81 (12)
Imputed interest on
long-term debt - - - 1
Non-cash consulting fees - 20 - 39
Stock-based compensation 406 495 896 997
Net change in non-cash
working capital (3,543) (709) (5,480) (422)
----------------------------------------------
(6,298) (7,240) (15,670) (12,226)
----------------------------------------------
Investing activities
Decrease in short-term
investments - 14,002 54,350 77,010
Purchase of property, plant
and equipment (296) (540) (507) (805)
----------------------------------------------
(296) 13,462 53,843 76,205
----------------------------------------------
Financing activities
Repayment of long-term debt (57) (30) (94) (93)
Deferred research and
development grant (463) (25) 10 3
Common shares issued
(purchased and cancelled),
net of issuance costs - 165 (169) 388
----------------------------------------------
(520) 110 (253) 298
----------------------------------------------
Increase (decrease) in cash
and cash equivalents
during the period (7,114) 6,332 37,920 64,277
Cash and cash equivalents -
Beginning of period 50,971 63,339 5,937 5,394
----------------------------------------------
Cash and cash equivalents -
End of period $ 43,857 $ 69,671 $ 43,857 $ 69,671
----------------------------------------------
----------------------------------------------
|
